The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Hypertension e-posters Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by